AZAD PHARMACEUTICALS INGREDIENTS AG PLEDGES 10 MILLION EURO INVESTMENT IN PRODUCTION OF RAW MATERIAL FOR MEDICINES
YEREVAN, March 18. / ARKA /. Swiss company AZAD Pharmaceuticals
Ingredients AG has pledged a 10 million euro investment in the next
five years into a pilot program on production of raw materials for
medicines in Armenia.
As part of that program a laboratory for the synthesis of medicinal
raw materials opened today in Yerevan. It was established under
a tripartite memorandum of cooperation signed last year by the
Yerevan-based Institute of Fine Organic Chemistry, Azad Pharmaceuticals
Ingredients AG and the Armenian Development Agency (ADA).
“Pharmacology is one of the most important sectors, which the
government has designated as a priority. With this laboratory Armenia,
famous for its research capacity, will receive a platform for using
knowledge and experience to develop pharmacology “, deputy economy
minister Emil Tarasyan said at the opening ceremony.
According to him, this is one of the best platforms where Armenian
researchers will be able to put together all the scientific potential
to conquer world markets.
In 2013, Azad Pharmaceuticals Ingredients AG had presented a
three-stage program for the production of medicinal raw material,
including creation of a research laboratory, implementation of
scientific research and organization of production.
At the moment, the Swiss company has implemented the first part of
the program by renovating and equipping five laboratories in the
Research Center for Organic and Pharmaceutical Chemistry. -0-